Royal Bank of Canada
MDNA

Royal Bank of Canada’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Royal Bank of Canada’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-173,945
Closed -$51K – 7872
2023
Q3 		$51K Buy
173,945
+55,185
+46% +$21.4K ﹤0.01% 5779
2023
Q2 		$57K Sell
118,760
-4,368
-4% -$2.7K ﹤0.01% 5716
2023
Q1 		$78K Buy
123,128
+4,878
+4% +$3.04K ﹤0.01% 5364
2022
Q4 		$54K Buy
118,250
+112,501
+1,957% +$68.7K ﹤0.01% 5832
2022
Q3 		$5K Buy
5,749
+424
+8% +$479 ﹤0.01% 6769
2022
Q2 		$6K Sell
5,325
-6,506
-55% -$6.95K ﹤0.01% 6611
2022
Q1 		$15K Buy
11,831
+978
+9% +$1.52K ﹤0.01% 6778
2021
Q4 		$18K Sell
10,853
-37,436
-78% -$77.6K ﹤0.01% 6851
2021
Q3 		$134K Buy
48,289
+32,312
+202% +$80K ﹤0.01% 5496
2021
Q2 		$48K Buy
15,977
+4,549
+40% +$16.8K ﹤0.01% 6079
2021
Q1 		$47K Sell
11,428
-11,999
-51% -$48.9K ﹤0.01% 5925
2020
Q4 		$110K Buy
+23,427
New +$94.4K ﹤0.01% 5289

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada's MDNA Position: Q4 2023 in Review

Royal Bank of Canada sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 173,945 shares — an estimated $51K sold.

Royal Bank of Canada first reported a position in MDNA in Q4 2020 and held it in 12 quarters. The position peaked at $134K in Q3 2021. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • Royal Bank of Canada reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 173,945 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $51K.
  • Royal Bank of Canada first reported a position in Medicenna Therapeutics Corp. Common Shares in Q4 2020 and held it in 12 quarters.
  • Royal Bank of Canada's Medicenna Therapeutics Corp. Common Shares position peaked at $134K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.